TIO LIVINGSTON: Open Payments
NPI 1447727672 · BRIDGEPORT, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,827 in 208 payments from 28 companies in 2025. Trend: 2023 $2,448 · 2024 $3,279 · 2025 $3,827
Food & beverage: $3,827
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 62 | $821 |
| AstraZeneca Pharmaceuticals LP | 20 | $478 |
| Indivior Inc. | 14 | $381 |
| PFIZER INC. | 17 | $318 |
| Corium, LLC | 22 | $291 |
| GlaxoSmithKline, LLC. | 8 | $150 |
| Axsome Therapeutics, Inc. | 9 | $145 |
| Astellas Pharma US Inc | 4 | $120 |
| Amgen Inc. | 6 | $108 |
| Vanda Pharmaceuticals Inc. | 5 | $107 |
Products named: VRAYLAR, SUBLOCADE, BREZTRI, Azstarys, NURTEC ODT, UBRELVY, TRELEGY ELLIPTA, Veozah.
Industry payments across CT — which companies pay providers there.
